Phio Pharmaceuticals Corp. (PHIO)
0.808
+0.01
(+1.00%)
USD |
NASDAQ |
Nov 06, 09:59
Phio Pharmaceuticals Price to Book Value : 0.7449 for Nov. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 0.7375 |
| November 04, 2026 | 0.8019 |
| November 03, 2026 | 0.8324 |
| November 02, 2026 | 0.8112 |
| October 30, 2026 | 0.7928 |
| October 29, 2026 | 0.7952 |
| October 28, 2026 | 0.8452 |
| October 27, 2026 | 0.8216 |
| October 26, 2026 | 0.7838 |
| October 23, 2026 | 0.7858 |
| October 22, 2026 | 0.8043 |
| October 21, 2026 | 0.825 |
| October 20, 2026 | 0.8224 |
| October 19, 2026 | 0.801 |
| October 16, 2026 | 0.803 |
| October 15, 2026 | 0.8535 |
| October 14, 2026 | 0.8754 |
| October 13, 2026 | 0.8615 |
| October 12, 2026 | 0.8499 |
| October 09, 2026 | 0.9023 |
| October 08, 2026 | 0.8971 |
| October 07, 2026 | 0.9214 |
| October 06, 2026 | 0.9167 |
| October 05, 2026 | 0.9136 |
| October 02, 2026 | 0.9081 |
| Date | Value |
|---|---|
| October 01, 2026 | 0.9219 |
| September 30, 2026 | 0.9495 |
| September 29, 2026 | 0.9495 |
| September 28, 2026 | 0.9311 |
| September 25, 2026 | 0.9311 |
| September 24, 2026 | 0.9403 |
| September 23, 2026 | 0.9403 |
| September 22, 2026 | 0.9219 |
| September 21, 2026 | 0.9311 |
| September 18, 2026 | 0.9495 |
| September 17, 2026 | 0.9403 |
| September 16, 2026 | 0.921 |
| September 15, 2026 | 0.9403 |
| September 14, 2026 | 0.9495 |
| September 11, 2026 | 0.9495 |
| September 10, 2026 | 0.9311 |
| September 09, 2026 | 0.9495 |
| September 08, 2026 | 0.9495 |
| September 04, 2026 | 0.9956 |
| September 03, 2026 | 1.023 |
| September 02, 2026 | 1.042 |
| September 01, 2026 | 1.014 |
| August 31, 2026 | 1.005 |
| August 28, 2026 | 1.042 |
| August 27, 2026 | 1.032 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| CapForce, Inc. | 1.005 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 17.28 |
| Anika Therapeutics, Inc. | 1.652 |
| BioCryst Pharmaceuticals, Inc. | -- |
Price to Book Value Related Metrics
| Price | 0.808 |
| Earnings Yield | -166.1% |
| Market Cap | 9.387M |